Skip to content
value.today

WISC Med, LLC

Total raised
$9 M
3 rounds on record
Latest round
$3 M
Jul 2025
First round on record
Apr 2020
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of WISC Med, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$3 MNo. 3$2 to $10 million

WISC Med, LLC: Raise no. 3, Jul 2025

Investors in this round

19 investors had bought by the notice of Aug 15, 2025: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Wisconsin

People named in the notice

  • James Berbee · Executive Officer, Director
  • Azita Hamedani · Director
  • David Allyn · Director
  • Paul Shain · Director
  • Scott Gucciardi · Director
  • William Schleicher · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James G. Berbee, Manager. Source: SEC Form D, newest notice filed Aug 15, 2025. Read the notice at the SEC.

equitySEC
Oct 2022$2 MNo. 2$2 to $10 million

WISC Med, LLC: Raise no. 2, Oct 2022

Investors in this round

20 investors had bought by the notice of Nov 9, 2022: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Wisconsin

People named in the notice

  • James G. Berbee · Executive Officer, Director
  • Azita G. Hamedani · Director
  • David G. Allyn · Director
  • Paul G. Shain · Director
  • Scott G. Gucciardi · Director
  • William G. Schleicher · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Berbee, Manager. Source: SEC Form D, newest notice filed Nov 9, 2022. Read the notice at the SEC.

equitySEC
Apr 2020$3 MNo. 1$2 to $10 million

WISC Med, LLC: Raise no. 1, Apr 2020

Investors in this round

26 investors had bought by the notice of May 6, 2020: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Wisconsin

People named in the notice

  • Harry S. Schutte · Executive Officer · Vice President of Operations
  • James G. Berbee · Executive Officer, Director · Chairman and Member of Issuer's Board of Managers
  • Azita G. Hamedani · Director · Member of Issuer's Board of Managers
  • David G. Allyn · Director · Member of Issuer's Board of Managers
  • Paul S. Shain · Director · Member of Issuer's Board of Managers
  • Scott S. Gucciardi · Director · Member of Issuer's Board of Managers
  • William S. Schleicher · Director · Member of Issuer's Board of Managers

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for research, development and general corporate purposes.”

Signed by James G. Berbee, Manager. Source: SEC Form D, newest notice filed May 6, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • WISC Med, LLC chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2025

That is all the official record says: WISC Med, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of WISC Med, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by WISC Med, LLC
NameRoleNamed in
James BerbeeExecutive officerAug 2025
James G. BerbeeExecutive officerNov 2022
Harry S. SchutteVice President of OperationsMay 2020
Azita HamedaniDirectorAug 2025
David AllynDirectorAug 2025
James BerbeeDirectorAug 2025
Paul ShainDirectorAug 2025
Scott GucciardiDirectorAug 2025
William SchleicherDirectorAug 2025
Azita G. HamedaniDirectorNov 2022
David G. AllynDirectorNov 2022
James G. BerbeeDirectorNov 2022
Paul G. ShainDirectorNov 2022
Scott G. GucciardiDirectorNov 2022
William G. SchleicherDirectorNov 2022
Paul S. ShainMember of Issuer's Board of ManagersMay 2020
Scott S. GucciardiMember of Issuer's Board of ManagersMay 2020
William S. SchleicherMember of Issuer's Board of ManagersMay 2020